These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15289310)

  • 1. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer.
    Fernández-Madrid F; Tang N; Alansari H; Granda JL; Tait L; Amirikia KC; Moroianu M; Wang X; Karvonen RL
    Cancer Res; 2004 Aug; 64(15):5089-96. PubMed ID: 15289310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of anti-56K/annexin XI autoantibodies in systemic autoimmune diseases.
    Misaki Y; Van Venrooij WJ; Pruijn GJ
    J Rheumatol; 1995 Jan; 22(1):97-102. PubMed ID: 7699691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
    Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
    Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
    Fernández Madrid F
    Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
    Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J
    J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of autoantibodies to annexin XI in systemic autoimmune diseases.
    Jorgensen CS; Levantino G; Houen G; Jacobsen S; Halberg P; Ullman S; Khamashta MA; Asmussen K; Oxholm P; Jorgensen MK; van Venrooij WJ; Wiik A
    Lupus; 2000; 9(7):515-20. PubMed ID: 11035417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.
    Kalniņa Z; Siliņa K; Meistere I; Zayakin P; Rivosh A; Abols A; Leja M; Minenkova O; Schadendorf D; Linē A
    J Immunol Methods; 2008 May; 334(1-2):37-50. PubMed ID: 18314130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient isolation of cDNA clones encoding rheumatoid arthritis autoantigens by lambda phage surface display.
    Niwa M; Fukuoka K; Fujimoto T; Maruyama IN
    J Biotechnol; 2004 Oct; 114(1-2):55-8. PubMed ID: 15464598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases.
    Iaccarino L; Ghirardello A; Canova M; Zen M; Bettio S; Nalotto L; Punzi L; Doria A
    Autoimmun Rev; 2011 Jul; 10(9):553-8. PubMed ID: 21527362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
    Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
    Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autoimmune diseases manifested by production of autoantibodies: the autoantigens identified by random peptide library.
    Jadali Z; Sanati MH
    Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):115-31. PubMed ID: 18780947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
    Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
    Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM; Piato S; Silva MA
    Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.